The Wegovy price list explained: what UK private treatment costs and why

What NICE guidance and the licence say about who qualifies

Before prices make sense, eligibility does. NICE recommends semaglutide for weight management in adults with a BMI of 35 or above and at least one weight-related comorbidity, used for a maximum of two years within a specialist weight management service. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, typically 2.5 kg/m² below the standard figure. The Wegovy licence itself is somewhat broader, it covers adults with a BMI of 30 or more, or 27 or above with a qualifying condition such as high blood pressure, type 2 diabetes or high cholesterol. Comparing Wegovy prices across UK providers makes most sense once you know which route you're taking, because NHS and private criteria differ considerably. Private prescribing follows the licensed criteria rather than NICE's NHS-access thresholds, which is why many people who don't yet qualify for NHS treatment are already receiving it privately. A prescriber assesses the full picture at consultation, a BMI figure alone doesn't decide anything. This is also why a legitimate private price always includes the cost of that clinical assessment, whether it's itemised separately or bundled in.

What the Wegovy list price in the UK actually includes, and what it often doesn't

A headline price for Wegovy in the UK private market can mean very different things. Some providers quote the cost of the pen or pens alone; the consultation, prescription fee and delivery are then charged separately. Others bundle everything. The practical difference between two providers whose headline figures look similar can be £50 or more per month once those extras are counted. NICE's appraisal of semaglutide for weight management, published as TA875, sets the clinical framework within which reputable providers operate, but it says nothing about what commercial services may charge. With the MHRA's approval in April 2026 of a dedicated single-dose 7.2mg Wegovy pen, the price list is also changing: this higher maintenance dose is newer to market, and availability and pricing vary. The NHS medicines information page for semaglutide is the right starting point for understanding what the medicine is and how it's taken, separate from any commercial pricing. If you want to understand what drives the Wegovy cost price and how it breaks down, that's worth reading before committing to a provider. If you want a clear breakdown before committing to a provider, our Wegovy discount price list sets out what reduced and bundled pricing can look like in practice. For many providers, the honest answer is that it doesn't. Worth checking.

Where nume sits on the price list, and why

nume is not positioned as the cheapest option on the Wegovy price list. That's a deliberate choice. Our single transparent price covers the consultation, the prescription, the medicine itself, free next-working-day DPD delivery, and priority aftercare seven days a week. There are no add-on fees and no subscription that auto-renews. Every repeat order goes through a fresh clinical review before anything is dispatched. The treatment page shows current pricing clearly. We don't list per-pen prices in general content because the right comparison isn't pen-versus-pen; it's the complete cost of safely supervised treatment versus something that looks cheaper before the extras arrive. If you're comparing, our page on Wegovy price gives a fuller picture of what drives the cost in the UK, which is a more useful exercise than scanning for the lowest number. Some people time their orders around payday or the start of a new month, with our Monday-to-Friday 12pm dispatch cut-off, ordering on a Monday morning means the pen typically arrives Tuesday. Our clinical team, led by a GPhC-registered Independent Prescriber, is profiled at our prescribers page if you'd like to know who reviews consultations.

Why the cheapest Wegovy listing is the wrong number to optimise for

Wegovy is a prescription-only medicine. The MHRA has issued repeated warnings about counterfeit and illegally traded weight-loss pens sold online, with large seizures of fake pens and the first illicit UK manufacturing site producing counterfeit tirzepatide pens raided in 2025. The same risk applies to semaglutide. Sellers offering these medicines without a full clinical assessment are a serious red flag, and if you're partway through the dose escalation schedule, our dedicated page on Wegovy 1 mg price explains what that particular step of treatment typically costs across providers. The GPhC register at pharmacyregulation.org is the definitive way to verify whether a pharmacy is legitimate; nume's GPhC premises registration is 9012878. Suspected counterfeit or illegally sold medicines can be reported through the MHRA's Yellow Card scheme. Price is a reasonable thing to consider. For a prescription medicine with a real clinical assessment behind it, it's just not the measure that keeps you safe. Start your free consultation at our treatment page and a prescriber will review your details the same day.